Immunome
IMNM
IMNM
142 hedge funds and large institutions have $739M invested in Immunome in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 142 → 142 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
97% less call options, than puts
Call options by funds: $1.07M | Put options by funds: $39.5M
Holders
142
Holding in Top 10
3
Calls
$1.07M
Puts
$39.5M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$17.1M | |
| 3 | +$9.26M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.2M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$5.91M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$8.59M | |
| 3 | -$5.22M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$5.05M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$4.01M |